|
AU2019301679A1
|
|
Dimeric immuno-modulatory compounds against cereblon-based mechanisms
|
|
AU2018302097A1
|
|
Compositions and methods for targeting CD33-expressing cancers
|
|
AU2017260460A1
|
|
A delta-opioid receptor targeted agent for molecular imaging and immunotherapy of cancer
|
|
AU2017230119A1
|
|
Icariin and icaritin derivatives
|
|
AU2016259007A1
|
|
Systems and methods for providing personalized radiation therapy
|
|
AU2015339032A1
|
|
Tetravalent TLR9 bispecific antibody
|
|
AU2015339063A1
|
|
TLR9 targeted cytotoxic agents
|
|
AU2008325187A1
|
|
Methods for detecting or monitoring cancer using LPC as a marker
|
